1) The document describes a pipeline for tumor classification using pathways and support vector machines (SVMs).
2) Pathway interactions are identified from lung squamous cell carcinoma patient data using similarity network fusion to cluster patients.
3) Discriminant genes and pathways are selected using discriminant fuzzy pattern analysis and enrichment analysis.
4) SVMs are used to classify patient pairs based on pathways, and significant pathways are identified with permutation tests.